GlassScriptPhysician profile
Mary E Anderson
NPI 1225418221
$1,856.36
in general payments reported to CMS, 2019-2025
16 companies · $899 in 2025
The $899 reported for 2025 was more than what 86% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $242 · 2023: $568 · 2024: $147 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,613.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $251.36 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Alexion Pharmaceuticals, INC. | $224.28 | 2023-2024 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $215.46 | 2023 | Enhertu, Calquence |
| Tactile Systems Technology INC | $153.09 | 2025 | Flexitouch Plus, Nimbl |
| Takeda Pharmaceuticals U.S.A., INC. | $141.58 | 2023-2024 | Livtencity, Entyvio |
| Seagen INC. | $119.70 | 2023 | Adcetris |
| Janssen Pharmaceuticals, INC | $117.60 | 2022 | |
| Bard Peripheral Vascular, INC. | $109.94 | 2025 | Rotarexs 6 F X 135 Cm |
| Abbott Laboratories | $109.77 | 2025 | Esprit |
| Organogenesis INC. | $106.51 | 2025 | Simplimax |
| Smith+Nephew, INC. | $84.72 | 2025 | Stravix Pl, Grafix Pl |
| Veloxis Pharmaceuticals, INC. | $80.02 | 2022 | |
| Boston Scientific Corporation | $54.22 | 2022-2025 | Embold Fibered |
| Terumo Medical Corporation | $46.14 | 2025 | R2p Misago, Glidewire, Angio-Seal |
| Astellas Pharma US INC | $28.11 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $13.86 | 2023 | Imbruvica |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.